Middle-term outcomes in renal transplant recipients with COVID-19: a national, multicenter, controlled study.

ABSTRACT:

Background

In this study, we evaluated 3-month clinical outcomes of kidney transplant recipients (KTR) recovering from COVID-19 and compared them with a control group.

Method

The primary endpoint was death in the third month. Secondary endpoints were ongoing respiratory symptoms, need for home oxygen therapy, rehospitalization for any reason, lower respiratory tract infection, urinary tract infection, biopsy-proven acute rejection, venous/arterial thromboembolic event, cytomegalovirus (CMV) infection/disease and BK viruria/viremia at 3 months.

Results

A total of 944 KTR from 29 different centers were included in this study (523 patients in the COVID-19 group; 421 patients in the control group). The mean age was 46 ± 12 years (interquartile range 37-55) and 532 (56.4%)

SUBMITTER: Oto OA 

PROVIDER: S-EPMC8903384 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature